Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction

We investigated the impact of chronic hypercorticosteronemia (due to neonatal monosodium L-glutamate, MSG, and treatment) on liver oxidative stress (OS), inflammation, and carbohydrate/lipid metabolism in adult male rats. We evaluated the peripheral concentrations of several metabolic and OS markers...

Full description

Bibliographic Details
Main Authors: Hernán Gonzalo Villagarcía, Vanesa Sabugo, María Cecilia Castro, Guillermo Schinella, Daniel Castrogiovanni, Eduardo Spinedi, María Laura Massa, Flavio Francini
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2016/7838290
id doaj-ec9247c2618c451383164db374ae0eaf
record_format Article
spelling doaj-ec9247c2618c451383164db374ae0eaf2020-11-24T23:10:05ZengHindawi LimitedInternational Journal of Endocrinology1687-83371687-83452016-01-01201610.1155/2016/78382907838290Chronic Glucocorticoid-Rich Milieu and Liver DysfunctionHernán Gonzalo Villagarcía0Vanesa Sabugo1María Cecilia Castro2Guillermo Schinella3Daniel Castrogiovanni4Eduardo Spinedi5María Laura Massa6Flavio Francini7Centro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaCentro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaCentro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaCátedra de Farmacología Básica, Facultad de Ciencias Médicas, UNLP and CICPBA, 1900 La Plata, ArgentinaInstituto Multidisciplinario de Biología Celular (IMBICE), CONICET-CICPBA-UNLP, 1900 La Plata, ArgentinaCentro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaCentro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaCentro de Endocrinología Experimental y Aplicada (CENEXA), UNLP-CONICET-FCM, 1900 La Plata, ArgentinaWe investigated the impact of chronic hypercorticosteronemia (due to neonatal monosodium L-glutamate, MSG, and treatment) on liver oxidative stress (OS), inflammation, and carbohydrate/lipid metabolism in adult male rats. We evaluated the peripheral concentrations of several metabolic and OS markers and insulin resistance indexes. In liver we assessed (a) OS (GSH and protein carbonyl groups) and inflammatory (IL-1b, TNFa, and PAI-1) biomarkers and (b) carbohydrate and lipid metabolisms. MSG rats displayed degenerated optic nerves, hypophagia, low body and liver weights, and enlarged adipose tissue mass; higher peripheral levels of glucose, triglycerides, insulin, uric acid, leptin, corticosterone, transaminases and TBARS, and peripheral and liver insulin resistance; elevated liver OS, inflammation markers, and glucokinase (mRNA/activity) and fructokinase (mRNA). Additionally, MSG liver phosphofructokinase-2, glucose-6-phosphatase (mRNA and activity) and glucose-6-phosphate dehydrogenase, Chrebp, Srebp1c, fatty acid synthase, and glycerol-3-phosphate (mRNAs) were increased. In conclusion adult MSG rats developed an insulin-resistant state and increased OS and serious hepatic dysfunction characterized by inflammation and metabolic signs suggesting increased lipogenesis. These features, shared by both metabolic and Cushing’s syndrome human phenotypes, support that a chronic glucocorticoid-rich endogenous environment mainly impacts on hepatic glucose cycle, displacing local metabolism to lipogenesis. Whether correcting the glucocorticoid-rich environment ameliorates such dysfunctions requires further investigation.http://dx.doi.org/10.1155/2016/7838290
collection DOAJ
language English
format Article
sources DOAJ
author Hernán Gonzalo Villagarcía
Vanesa Sabugo
María Cecilia Castro
Guillermo Schinella
Daniel Castrogiovanni
Eduardo Spinedi
María Laura Massa
Flavio Francini
spellingShingle Hernán Gonzalo Villagarcía
Vanesa Sabugo
María Cecilia Castro
Guillermo Schinella
Daniel Castrogiovanni
Eduardo Spinedi
María Laura Massa
Flavio Francini
Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction
International Journal of Endocrinology
author_facet Hernán Gonzalo Villagarcía
Vanesa Sabugo
María Cecilia Castro
Guillermo Schinella
Daniel Castrogiovanni
Eduardo Spinedi
María Laura Massa
Flavio Francini
author_sort Hernán Gonzalo Villagarcía
title Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction
title_short Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction
title_full Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction
title_fullStr Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction
title_full_unstemmed Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction
title_sort chronic glucocorticoid-rich milieu and liver dysfunction
publisher Hindawi Limited
series International Journal of Endocrinology
issn 1687-8337
1687-8345
publishDate 2016-01-01
description We investigated the impact of chronic hypercorticosteronemia (due to neonatal monosodium L-glutamate, MSG, and treatment) on liver oxidative stress (OS), inflammation, and carbohydrate/lipid metabolism in adult male rats. We evaluated the peripheral concentrations of several metabolic and OS markers and insulin resistance indexes. In liver we assessed (a) OS (GSH and protein carbonyl groups) and inflammatory (IL-1b, TNFa, and PAI-1) biomarkers and (b) carbohydrate and lipid metabolisms. MSG rats displayed degenerated optic nerves, hypophagia, low body and liver weights, and enlarged adipose tissue mass; higher peripheral levels of glucose, triglycerides, insulin, uric acid, leptin, corticosterone, transaminases and TBARS, and peripheral and liver insulin resistance; elevated liver OS, inflammation markers, and glucokinase (mRNA/activity) and fructokinase (mRNA). Additionally, MSG liver phosphofructokinase-2, glucose-6-phosphatase (mRNA and activity) and glucose-6-phosphate dehydrogenase, Chrebp, Srebp1c, fatty acid synthase, and glycerol-3-phosphate (mRNAs) were increased. In conclusion adult MSG rats developed an insulin-resistant state and increased OS and serious hepatic dysfunction characterized by inflammation and metabolic signs suggesting increased lipogenesis. These features, shared by both metabolic and Cushing’s syndrome human phenotypes, support that a chronic glucocorticoid-rich endogenous environment mainly impacts on hepatic glucose cycle, displacing local metabolism to lipogenesis. Whether correcting the glucocorticoid-rich environment ameliorates such dysfunctions requires further investigation.
url http://dx.doi.org/10.1155/2016/7838290
work_keys_str_mv AT hernangonzalovillagarcia chronicglucocorticoidrichmilieuandliverdysfunction
AT vanesasabugo chronicglucocorticoidrichmilieuandliverdysfunction
AT mariaceciliacastro chronicglucocorticoidrichmilieuandliverdysfunction
AT guillermoschinella chronicglucocorticoidrichmilieuandliverdysfunction
AT danielcastrogiovanni chronicglucocorticoidrichmilieuandliverdysfunction
AT eduardospinedi chronicglucocorticoidrichmilieuandliverdysfunction
AT marialauramassa chronicglucocorticoidrichmilieuandliverdysfunction
AT flaviofrancini chronicglucocorticoidrichmilieuandliverdysfunction
_version_ 1725608228070359040